If using monotherapy at 4.5 mg/week, vial counts roughly double from the 2.4 mg/week math above
Atteno M, Peluso R, Costa L, et al
Several rodent studies link BPC-157 to the VEGF-receptor-2 / Akt / endothelial nitric oxide synthase (eNOS) signaling axis, which would connect its reported angiogenic and vasodilatory effects to a single upstream pathway
The efficacy of liraglutide on weight management was subsequently surpassed by semaglutide, which, when administered weekly at a dose of 2.4 mg in obese patients without diabetes, resulted in a weight reduction of 12.4% compared to placebo in the STEP 1 study [46], and a reduction of 9.4% compared to liraglutide 3.0 mg in the STEP-8 study [47]
Always use a new syringe for every dose and throw it away properly in a sharps container
Short-term (days to a few weeks) is possible but shortens shelf life significantly